Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.

Source:http://linkedlifedata.com/resource/pubmed/id/11051233

Download in:

View as

General Info

PMID
11051233